Breaking News
March 22, 2018 - Vitamin D deficiency linked to metabolic syndrome in postmenopausal women
March 22, 2018 - Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery
March 22, 2018 - iPads and Cancer; Clot Retrieval and Stroke: It’s PodMed Double T!
March 22, 2018 - Premature births linked to changes in mother’s bacteria
March 22, 2018 - Brain SPECT scans predict treatment outcomes in patients with depression
March 21, 2018 - Researchers succeed in integrating artificial organelles into cells of living organism
March 21, 2018 - Researchers discover ‘missing mutation’ in severe infant epilepsy
March 21, 2018 - Researchers develop statistics-based computational scheme to zoom in on brain function
March 21, 2018 - Verge joins Genomics England’s Discovery Forum industry partnership
March 21, 2018 - Trovagene Announces First Patient Successfully Completes Cycle 1 of Treatment with PCM-075 in Combination with Low Dose Cytarabine (LDAC) in AML Trial
March 21, 2018 - Congenital Cardiac Cath Tx Often Strays from Guidelines
March 21, 2018 - Marked increase in cardiovascular risk factors in women after preeclampsia
March 21, 2018 - New app may help predict, track manic and depressive episodes in bipolar patients
March 21, 2018 - Discovery of genes could lead to development of novel therapies for EBV-related cancers
March 21, 2018 - High-fat, high-cholesterol diet depletes ranks of artery-protecting immune cells
March 21, 2018 - Research misconduct allegations shadow likely CDC appointee
March 21, 2018 - Most Breast Ca Patients Fail to Get Genetic Counseling
March 21, 2018 - Lopsided ear function can lead to lopsided brain development
March 21, 2018 - Acupuncture helps manage menopausal symptoms, review finds
March 21, 2018 - Motor skill training may contribute to reading skills in obese children
March 21, 2018 - Poor dental health may be related to increased diabetes risk
March 21, 2018 - Chronic opioid users at increased risk of complications after spinal fusion surgery
March 21, 2018 - NSAID use linked to increased risk of atrial fibrillation
March 21, 2018 - Scientists develop brain “stethoscope” that can detect silent seizures
March 21, 2018 - New method predicts effects of global warming on disease
March 21, 2018 - Insurance Company Hurdles Burden Doctors, May Harm Patients
March 21, 2018 - Renal Transplant from HCV-Positive Donors Feasible
March 21, 2018 - Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
March 21, 2018 - Research reveals brain mechanism involved in language learning
March 21, 2018 - Many parents still hesitate to try early peanut introduction, survey finds
March 21, 2018 - Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
March 21, 2018 - Study reveals impact of prostate cancer on wives and partners of sufferers
March 21, 2018 - ‘Almost a Miracle Drug’: What We Heard This Week
March 21, 2018 - Study shows NIH spent >$100 billion on basic science for new medicines
March 21, 2018 - Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
March 21, 2018 - Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
March 21, 2018 - Increase in coffee consumption may help battle against colon cancer
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
March 20, 2018 - ECG Patch Ups At-Home Afib Diagnosis in mSToPS Trial
March 20, 2018 - ROS-scavenging nanozymes for anti-inflammation therapeutics
March 20, 2018 - Genomics England announces appointment of global genomics pioneer as first CEO
March 20, 2018 - Test flight at German Aerospace Center in Cologne demonstrates functionality of deficopter
March 20, 2018 - Music therapy helps treat combat-related psychological injuries in military personnel
March 20, 2018 - Innovative psychotherapeutic treatment protocol for obsessive-compulsive disorders
March 20, 2018 - Weight loss after lap-band surgery alleviates arthritic knee pain
March 20, 2018 - New diabetes drug may help obese people shed body weight
March 20, 2018 - Novel Peanut OIT a Winner in Phase III Trial
March 20, 2018 - Can gene therapy be harnessed to fight the AIDS virus?
March 20, 2018 - Education and academic achievement can lessen effects of child abuse, neglect
March 20, 2018 - Researchers develop new algorithm to make CPR more effective
CDC recommends new vaccine for shingles

CDC recommends new vaccine for shingles

image_pdfDownload PDFimage_print

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix.

This new vaccine since then has received the FDA approval this Monday. A federal committee of experts that advises the Centre of Disease Prevention and Control (CDC) yesterday (25th of October 2017), recommends the use of Shingrix for all persons over 50 years of age.

Shingles / herpes zoster. Image Credit: SneSivan / Shutterstock

Shingles / herpes zoster. Image Credit: SneSivan / Shutterstock

The Advisory Committee on Immunization Practices advises the CDC on current practices. The committee said that adults who have already received the earlier approved vaccine Zostavax (a shingles vaccine made by Merck) are to be vaccinated again with this new vaccine Shingrix. Shingrix, the committee said, is to be preferred over Zostavax. Until now the only vaccine against herpes zoster was Zostavax that was approved in 2006 for persons over the age of 60 years.

The committee has found that Zostavax is 51 percent effective in preventing the herpes zoster or shingles and 67 percent effective against postherpetic neuralgia whereas Shingrix is 97 percent effective in preventing shingles between ages 50 and 69 years. Shingrix is 91 percent effective in preventing shingles in those over 70 years. Shingrix can prevent postherpetic neuralgia in 91 percent cases over 50 years. These results have been studied in over 38,000 participants making the results reliable. With time Zostavax loses its efficacy. Within one year of vaccination the efficacy of Zostavax is lost by 15 to 25 percent. Within 9 years the protection is lost. Shingrix till date has been studied for up to four years only and it has been seen that its efficacy remains 85 percent for up to four years post vaccination.

According to Dr. Kathleen Dooling, a medical officer in the CDC’s division of viral disease, the final recommendation is expected to be released early next year. Dr. Dooling said, “The Shingrix vaccine has the potential to prevent tens of thousands of cases of shingles and its complications.”

Shingles and its Vaccines

Shingles or herpes zoster is actually a reactivation of the varicella-zoster virus that had caused a chicken pox infection in the person previously. The varicella zoster virus usually remains dormant in a person’s body and in times of weakened immunity such as in old age or during disease, the virus resurfaces as the painful blisters.

The blisters usually cluster in one place on one side of the body leading to burning, tingling or numbing pain. This gets dry and forms crusts over 2 to 3 weeks. The rash affects one side of the torso or may appear over face, forehead, eyes, mouth, and ears on one side. It typically follows distribution and branches of a nerve. Facial shingles is called Ramsay Hunt Syndrome. Sometimes the nerve pain may persist in 10 to 18 percent individuals. This is called Post herpetic neuralgia. When shingles affects the eyes or ears, it can leave a person blind or deaf. According to the CDC, there are approximately 1 million new cases of shingles each year in the US. 20 million people over the age of 60 have received the Zostavax vaccine.

There are essentially two types of vaccines against viral infections;

  • Live attenuated vaccine wherein weaker version of the virus is introduced in the body with the vaccine dose to teach the body’s immune system to fight the virus. This way when the virus actually is encountered, the body remembers and fights the infection successfully.
  • Subunit vaccine where only a part of the dead virus is introduced into the body. This subunit is an essential part of the virus that the body must recognize. This way too the body learns how to fight the virus when it really encounters it.

Zostavax is a live attenuated vaccine whereas Shingrix is a non-live, subunit vaccine. Because a whole weakened virus is not introduced with the vaccine the risk of getting side effects and adverse events with the vaccine is lower with Shingrix. Zostavax is given as a single shot. For Shingrix the recommended dosage is one shot each given at two months interval.

GSK has assured that the new vaccine would be available on the shelves soon. It is expected to cost about $280. Zostavax costs $223.

Tagged with:

About author

Related Articles